
ABLE Human Motion, a Barcelona-based company building cutting-edge rehabilitation technology, has received the CE Mark under the new Medical Device Regulation (MDR) for its revolutionary ABLE Exoskeleton: the lightest adjustable, hip-knee-powered exoskeleton on the EU market for spinal cord injury rehabilitation. This regulatory approval enables the commercialization of the device

We are thrilled to announce a groundbreaking partnership between ABLE Human Motion and Fundación Esclerosis Múltiple Madrid (FEMM) to initiate a new clinical trial to validate the ABLE Exoskeleton in people affected by multiple sclerosis (MS). This collaboration marks a significant step forward in our commitment to enabling mobility for

In February, we had a very special event: our team visited the National Hospital for Paraplegics in Toledo and demonstrated our ABLE Exoskeleton to their clinical professionals. The National Hospital for Paraplegics in Toledo is the largest hospital in Spain for the evaluation, diagnosis and treatment of Spinal Cord Injury

As we approach the last days of 2023, it is time to look back at the milestones achieved and the most important moments of the year. We also want to take this opportunity to recognize all the great work and efforts of the ABLE Human Motion team, as well as

On September 22nd, our Clinical Specialist, Helena López, and our CEO, Alfons Carnicero, were invited to Guttmann Barcelona, a highly specialized rehabilitation clinic in Barcelona. There, they presented the novel ABLE Exoskeleton, a revolutionary tool for neurorehabilitation, to the entire clinical staff of Guttmann Barcelona, led by the Head of